NSIM
KRRO icon

North Star Investment Management’s Korro Bio KRRO Stock Holding History

North Star Investment Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.4K Hold
1,800
– – ﹤0.01% 888
2025
Q4 		$14.4K Hold
1,800
– – ﹤0.01% 896
2025
Q3 		$86.2K Hold
1,800
– – 0.01% 554
2025
Q2 		$22.5K Hold
1,800
– – ﹤0.01% 776
2025
Q1 		$31.3K Hold
1,800
– – ﹤0.01% 700
2024
Q4 		$68.5K Buy
1,800
+800
+80% +$41.1K ﹤0.01% 569
2024
Q3 		$33.4K Sell
1,000
-1,000
-50% -$42.1K ﹤0.01% 661
2024
Q2 		$67.7K Buy
2,000
+1,000
+100% +$55.3K 0.01% 554
2024
Q1 		$90K Hold
1,000
– – 0.01% 524
2023
Q4 		$47.9K Sell
1,000
-1,400
-58% -$46.1K ﹤0.01% 598
2023
Q3 		$44.4K Buy
2,400
+1,200
+100% +$30.1K ﹤0.01% 608
2023
Q2 		$20.8K Hold
1,200
– – ﹤0.01% 738
2023
Q1 		$30.2K Hold
1,200
– – ﹤0.01% 695
2022
Q4 		$231K Hold
1,200
– – 0.02% 403
2022
Q3 		$107K Hold
1,200
– – 0.01% 440
2022
Q2 		$90K Hold
1,200
– – 0.01% 460
2022
Q1 		$127K Buy
+1,200
New +$229K 0.01% 432

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

North Star Investment Management's KRRO Position: Q1 2026 in Review

North Star Investment Management held its Korro Bio (KRRO) position steady in Q1 2026 at 1,800 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #888.

North Star Investment Management first reported a position in KRRO in Q1 2022 and has held it in 17 quarters since. The position peaked at $231K in Q4 2022. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • North Star Investment Management held 1,800 shares of Korro Bio worth $20.4K as of Q1 2026.
  • North Star Investment Management left its Korro Bio share count unchanged in Q1 2026.
  • Korro Bio made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #888 holding.
  • North Star Investment Management first reported a position in Korro Bio in Q1 2022 and has held it in 17 quarters since.
  • North Star Investment Management's Korro Bio position peaked at $231K in Q4 2022.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.